Navigation Links
Hydration startup Drip Drop Inc. raises 2.3 million in just 10 days
Date:7/12/2013

SAN FRANCISCO, July 12, 2013 /PRNewswire/ -- Only 10 days after announcing a $3 million Series A-1 financing round, Drip Drop Inc., inventor of medical grade hydration products, has executed the initial close on $2.3 million from a group of investors led by Pacific Advantage Capital, with the round closing July 29th. New funds will be used to add key personnel and scale the company's operating infrastructure, supporting an expansion of leading hospital and pharmacy distribution. The close comes just weeks into Anne Kallin Zehren's tenure as CEO.

Drip Drop® is an innovative rehydration solution that combines best-in-class medical technology with great taste. Developed by Eduardo Dolhun MD, a Mayo trained physician and Stanford Adjunct Assistant Clinical Professor, Drip Drop's formula helps prevent dehydration, maintain electrolyte balance, and replenish fluids lost through illness or activity.  Tested worldwide in the most challenging circumstances, Drip Drop® has won early adoption by a broad spectrum of users that include the Stanford University Medical Center, UCSF Medical Center, elite athletes, U.S. Special Forces, humanitarian workers, pharmacists, and patients with chronic illness.

"This investment allows us to continue fast-tracking our work with the country's top medical institutions, retailers, and influencers," said Zehren, who started at Drip Drop in April. "It speaks volumes about Drip Drop's potential that 78% of this round came so quickly from our existing shareholders - a full 75% of them reinvested, with the vast majority increasing their investment level. In my 20 years as an executive, it's absolutely rare to find a startup with such promise at such an early stage."

"With Anne's leadership, the Drip Drop team is driving terrific performance," said David Zezza, partner at Pacific Adva
'/>"/>

SOURCE Drip Drop Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. RenovoRx Named Winner of 2013 TiE50 "Top Startup"
2. Immune Pharmaceuticals CEO to Chair BIO International Panel "Can Israel Become the Next Biotech Startup Nation?"
3. University of Michigans Zell Lurie Institute Awards $112,000 to Promising Student Startups in 30th Annual Business Plan Competition and Dare to Dream Grant Program
4. Midwest Health Care Startups Raise $511 Million in First Half of 2012
5. Midwest Health Care Startups Raise $491 Million in First Half of 2012
6. ViaCyte, Inc. raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes
7. Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
8. TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
9. Protagonist Therapeutics Raises $14 Million in Series B Venture Financing
10. AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year
11. NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
(Date:12/24/2014)... CHENGDU, China, Dec. 24, 2014 /PRNewswire/  -- Tianyin ... a pharmaceutical company that specializes in the patented ... and active pharmaceutical ingredients (API) released unaudited preliminary ... year 2015. Fiscal Year 2015 Ended ... was $9.7 million compared with $14.7 million in ...
(Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... 2012  GP Strategies Corporation (NYSE: GPX ), ... sales and technical training, e-Learning solutions, management consulting and ... CFO Sharon Esposito-Mayer will speak at the Robert W. ... 10:55 a.m. ET. The conference will be held at ...
... nation,s leader in pain medication monitoring, commends the ... For Patients On Long-Term Opioid Therapy," unveiled Friday ... Academy of Pain Medicine,s (AAPM) 28th Annual Meeting ... seek to answer key questions that physicians may ...
Cached Medicine Technology:Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy 2Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy 3
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... drug which is typically used for treating colorectal cancer. ... treating gastric cancer and pancreatic cancer. TS-1 is composed ... first approved in 1999 in Japan for the treatment ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying women’s ... discounted prom dresses, most of which are priced under ... company, the promotion is valid until Jan. 22, 2015; ... UK market. , The prom dresses in this new ... A-line strapless, empire strapless chiffon, one shoulder, floor-length, V-neck ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- The risk ... the holidays, so you need to be extra cautious, ... Day, we see a significant increase in patients coming ... at the Suffolk County Volunteer Firefighters Burn Center of ... celebrations should be full of joy, but if not ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 AngelWeddingDress.com tries ... to the online realm. Today, the business has introduced ... a site-wide prom dress promotion. , The new prom ... each and every dress lover. They are specially designed ... 2015 prom dresses should visit its website before ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... 29 A federal court in San Francisco has ... Inc. ("Pfizer") about the marketing of the prescription drugs ... In re Bextra and Celebrex Marketing, Sales Practices, ... 1699, pending in the United States District Court for ...
... Response, an unprecedented partnership created to help ensure the continued ... emergency, has been put on Alert Status as concerns grow ... in the United States."Americans need to know that the medicines ... said Billy Tauzin, president and CEO of the Pharmaceutical Research ...
... services hires former Ernst & Young and Capgemini ... Virtify, Inc. ( www.virtify.com ), ... for life sciences, today announced the addition of ... executive, as executive vice president of commercial operations. ...
... On 22 and 23 June 2009, the Prostate ... be held in the Beurs van Berlage in ... from laboratory, clinical or population studies into clinical ... , The European Association of Urology (EAU) provides ...
... zebrafish could hold the key to stem cell treatments for ... have found that these fish are able to produce motor ... speaking, walking and breathing in humans when they repair ... small molecules with a view to finding drugs that could ...
... OneBeacon Professional Partners, a member of OneBeacon Insurance ... two new comprehensive management liability insurance solutions designed ... The Health Care Organization Management Liability product ... nonprofit organizations that offer health care services including: ...
Cached Medicine News:Health News:$89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements 2Health News:Rx Response Raised to 'Alert Status' in Response to Growing Swine Flu Threat 2Health News:Rx Response Raised to 'Alert Status' in Response to Growing Swine Flu Threat 3Health News:Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations 2Health News:Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations 3Health News:Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations 4Health News:EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results 2Health News:Zebrafish offer clues to treatments for motor neurone disease 2Health News:OneBeacon Professional Partners Expands Directors & Officers Coverage for Health Care Organizations, Nonprofit Organizations 2Health News:OneBeacon Professional Partners Expands Directors & Officers Coverage for Health Care Organizations, Nonprofit Organizations 3Health News:OneBeacon Professional Partners Expands Directors & Officers Coverage for Health Care Organizations, Nonprofit Organizations 4
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... Central platform with integrated neck. Piston ... utilizing an internal spring to recoil ... Cutting Block fits into precision milled ... blades sized 6.25 - 9.0mm. Designed ...
... Central platform with integrated neck. Piston ... utilizing an internal spring to recoil ... Cutting Block fits into precision milled ... blades sized 6.25 - 9.0mm. Designed ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: